Literature DB >> 12406891

Evidence for naive T-cell repopulation despite thymus irradiation after autologous transplantation in adults with multiple myeloma: role of ex vivo CD34+ selection and age.

Marion Malphettes1, Guislaine Carcelain, Pierre Saint-Mezard, Véronique Leblond, Hester Korthals Altes, Jean-Pierre Marolleau, Patrice Debré, Jean-Claude Brouet, Jean-Paul Fermand, Brigitte Autran.   

Abstract

Immunodeficiency following autologous CD34+-purified peripheral blood stem cell (PBSC) transplantation could be related to T-cell depletion of the graft or impaired T-cell reconstitution due to thymus irradiation. Aiming to assess the role of irradiated thymus in T-cell repopulation, we studied 32 adults with multiple myeloma, randomly assigned to receive high-dose therapy including total body irradiation (TBI) followed by autologous transplantation with either unselected or CD34+-selected PBSCs. The median number of reinfused CD3+ cells was lower in the selected group (0.03 versus 14 x 10(6)/kg; P =.002). Lymphocyte subset counts were evaluated from month 3 to 24 after grafting. Naive CD4+ T cells were characterized both by phenotype and by quantification of T-cell receptor rearrangement excision circles (TRECs). The reconstitution of CD3+ and CD4+ T cells was significantly delayed in the CD34+-selected group, but eventually led to counts similar to those found in the unselected group after month 12. Mechanism of reconstitution differed, however, between both groups. Indeed, a marked increase in the naive CD62L+CD45RA+CD4+ subset was observed in the selected group, but not in the unselected group in which half of the CD45RA+CD4+ T cells appear to be CD62L-. Age was identified as an independent adverse factor for CD4+ and CD62L+CD45RA+CD4+ T-cell reconstitution. Our results provide evidence that infusing PBSCs depleted of T cells after TBI in adults delays T-cell reconstitution but accelerates thymic regeneration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406891     DOI: 10.1182/blood-2002-06-1929

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantation.

Authors:  G Andreola; M Chittenden; J Shaffer; A B Cosimi; T Kawai; P Cotter; S A Locascio; T Morokata; B R Dey; N T Tolkoff-Rubin; F Preffer; T Bonnefoix; K Kattleman; T R Spitzer; D H Sachs; M Sykes
Journal:  Am J Transplant       Date:  2011-06       Impact factor: 8.086

2.  Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial.

Authors:  Edward A Stadtmauer; Dan T Vogl; Eline Luning Prak; Jean Boyer; Nicole A Aqui; Aaron P Rapoport; Kenyetta R McDonald; Xiaoling Hou; Heather Murphy; Rita Bhagat; Patricia A Mangan; Anne Chew; Elizabeth A Veloso; Bruce L Levine; Robert H Vonderheide; Abbas F Jawad; Carl H June; Kathleen E Sullivan
Journal:  Blood       Date:  2010-09-23       Impact factor: 22.113

3.  Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).

Authors:  Jan Storek; Zhao Zhao; Eugene Lin; Thomas Berger; Peter A McSweeney; Richard A Nash; Yoshiki Akatsuka; Monja D Metcalf; Hailing Lu; Tomas Kalina; Markus Reindl; Rainer Storb; John A Hansen; Keith M Sullivan; George H Kraft; Daniel E Furst; David G Maloney
Journal:  Clin Immunol       Date:  2004-12       Impact factor: 3.969

4.  Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation.

Authors:  C Pratesi; C Simonelli; S Zanussi; R Talamini; M T Bortolin; R Tedeschi; A Marus; C Caffau; M Michieli; U Tirelli; P De Paoli
Journal:  Clin Exp Immunol       Date:  2007-10-11       Impact factor: 4.330

5.  Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant.

Authors:  Maud Mavigner; Benjamin Watkins; Benton Lawson; S Thera Lee; Ann Chahroudi; Leslie Kean; Guido Silvestri
Journal:  PLoS Pathog       Date:  2014-09-25       Impact factor: 6.823

6.  CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.

Authors:  Masahiro Ayano; Hiroshi Tsukamoto; Hiroki Mitoma; Yasutaka Kimoto; Mitsuteru Akahoshi; Yojiro Arinobu; Toshihiro Miyamoto; Takahiko Horiuchi; Hiroaki Niiro; Koji Nagafuji; Mine Harada; Koichi Akashi
Journal:  Arthritis Res Ther       Date:  2019-01-22       Impact factor: 5.156

7.  Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT.

Authors:  Mariona Baliu-Piqué; Vera van Hoeven; Julia Drylewicz; Lotte E van der Wagen; Anke Janssen; Sigrid A Otto; Menno C van Zelm; Rob J de Boer; Jürgen Kuball; Jose Am Borghans; Kiki Tesselaar
Journal:  Elife       Date:  2021-02-04       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.